
Protalix BioTherapeutics, Inc.
PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31
Reports and events: 399 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2012-06-2507:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-12-036152 |
| 2012-06-2208:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-035911 |
| 2012-06-1816:57 ET | 8-K | 5.07 Shareholder vote results | 0001144204-12-035275 |
| 2012-06-1107:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-034096 |
| 2012-05-2907:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-12-032099 |
| 2012-05-2108:12 ET | DEF 14A | Proxy statementPeriod 2012-06-17 | 0001144204-12-030772 |
| 2012-05-1007:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-12-027345 |
| 2012-05-0916:33 ET | 10-Q | Quarterly reportPeriod 2012-03-31 | 0001144204-12-027198 |
| 2012-05-0206:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-025455 |
| 2012-03-1917:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-12-015923 |
| 2012-02-2716:13 ET | 10-K | Annual reportPeriod 2011-12-31 | 0001144204-12-011082 |
| 2012-02-2307:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-010509 |
| 2012-02-1617:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-009665 |
| 2012-02-1516:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-009380 |
| 2012-02-0906:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-006728 |
| 2012-01-2606:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-12-003991 |
| 2011-12-1316:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-11-069608 |
| 2011-12-0607:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-11-068460 |
| 2011-12-0106:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-11-067780 |
| 2011-11-1007:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-11-062742 |
| 2011-11-0816:09 ET | 8-K | 5.07 Shareholder vote results | 0001144204-11-062019 |
| 2011-11-0716:09 ET | 10-Q | Quarterly reportPeriod 2011-09-30 | 0001144204-11-061636 |
| 2011-10-2607:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-11-059337 |
| 2011-09-2107:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-11-054042 |
| 2011-09-1916:42 ET | DEF 14A | Proxy statementPeriod 2011-11-07 | 0001144204-11-053749 |
| 2011-09-1317:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-11-052800 |
| 2011-09-0808:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-11-051725 |
| 2011-08-1708:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-11-048074 |
| 2011-08-0806:04 ET | 10-Q | Quarterly reportPeriod 2011-06-30 | 0001144204-11-044353 |
| 2011-08-0109:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-11-043025 |
| 2011-06-1516:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-11-035916 |
| 2011-05-1216:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-11-049414 |
| 2011-05-0417:27 ET | 10-Q | Quarterly reportPeriod 2011-03-31 | 0000950123-11-044803 |
| 2011-04-2716:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-11-040029 |
| 2011-04-0716:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-11-033732 |
| 2011-03-2316:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000950123-11-028238 |
| 2011-03-1806:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-11-026581 |
| 2011-03-1716:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-11-026403 |
| 2011-02-2506:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-11-018222 |
| 2011-02-2317:19 ET | 10-K | Annual reportPeriod 2010-12-31 | 0000950123-11-017213 |
| 2011-02-1813:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-11-015571 |
| 2011-01-2711:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-11-005907 |
| 2011-01-2417:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-11-004909 |
| 2011-01-2016:18 ET | SC 13D/A | Ownership report, active investor, amended | 0001144204-11-003118 |
| 2011-01-1909:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-11-003615 |
| 2011-01-0408:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950123-11-000165 |
| 2010-11-2916:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-109328 |
| 2010-11-1016:47 ET | 8-K | 5.07 Shareholder vote results | 0000950123-10-103946 |
| 2010-11-0816:42 ET | 10-Q | Quarterly reportPeriod 2010-09-30 | 0000950123-10-102510 |
| 2010-11-0206:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950123-10-099118 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.